Pfizer (PFE) SEC Filings: History & Chart

Pfizer Inc. (PFE)PFEPfizer Inc.

About Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.

New York City, NY

75,000 employees

www.pfizer.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Albert Bourla

View full financials

Form	Filing Date	Accepted	Document
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 13, 2026	Jul 13, 2026	View filing
4	Jul 1, 2026	Jul 1, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
8-K	Jun 18, 2026	Jun 18, 2026	View filing
8-K	Jun 18, 2026	Jun 18, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
11-K	Jun 16, 2026	Jun 16, 2026	View filing
11-K	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 10, 2026	Jun 10, 2026	View filing
4	Jun 1, 2026	Jun 1, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
SC 13G/A	May 12, 2026	May 12, 2026	View filing
13F-HR	May 12, 2026	May 12, 2026	View filing
S-8	May 5, 2026	May 5, 2026	View filing
10-Q	May 5, 2026	May 5, 2026	View filing
8-K	May 5, 2026	May 5, 2026	View filing
4	May 4, 2026	May 4, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing

SEC Filings

Recent Filings